These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37226746)

  • 1. Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union.
    Van de Wiele VL; Raymakers A; Kesselheim AS; Rome BN
    J Law Med Ethics; 2023; 51(1):213-216. PubMed ID: 37226746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrete choice experiment to investigate preferences for incentives to promote antimicrobial research and development.
    Rohde L; Mossialos E; Beaudart C; Joos A; Heikkinen I; Holland S; Hiligsmann M
    J Glob Antimicrob Resist; 2022 Jun; 29():42-48. PubMed ID: 35172202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe.
    Årdal C; Lacotte Y; Ploy MC
    Clin Infect Dis; 2020 Nov; 71(8):1994-1999. PubMed ID: 32060511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis.
    Rome BN; Kesselheim AS
    Clin Infect Dis; 2020 Oct; 71(7):1671-1675. PubMed ID: 31630159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy.
    Outterson K; McDonnell A
    Health Aff (Millwood); 2016 May; 35(5):784-90. PubMed ID: 27140983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.
    Unemo M; Ison CA; Cole M; Spiteri G; van de Laar M; Khotenashvili L
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv42-6. PubMed ID: 24243879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union:
    't Hoen EFM; Boulet P; Baker BK
    J Pharm Policy Pract; 2017; 10():19. PubMed ID: 28670455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
    Finch R; Hunter PA
    J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased momentum in antimicrobial resistance research.
    Matthiessen L; Bergström R; Dustdar S; Meulien P; Draghia-Akli R
    Lancet; 2016 Aug; 388(10047):865. PubMed ID: 27597459
    [No Abstract]   [Full Text] [Related]  

  • 11. Incentives for orphan drug research and development in the United States.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Visaria J
    Orphanet J Rare Dis; 2008 Dec; 3():33. PubMed ID: 19087348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA).
    Spiteri G; Cole M; Unemo M; Hoffmann S; Ison C; van de Laar M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv16-8. PubMed ID: 24243874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study.
    Bragginton EC; Piddock LJ
    Lancet Infect Dis; 2014 Sep; 14(9):857-68. PubMed ID: 25065509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial Drugs: The Last Frontier.
    Shlaes DM
    ACS Infect Dis; 2020 Jun; 6(6):1313-1314. PubMed ID: 32527094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial sensitivity--A natural resource to be protected by a Pigouvian tax?
    Vågsholm I; Höjgård S
    Prev Vet Med; 2010 Aug; 96(1-2):9-18. PubMed ID: 20570379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Europe's Agenda For Antimicrobial Resistance And Other Challenges.
    Weil AR
    Health Aff (Millwood); 2018 Jun; 37(6):850-853. PubMed ID: 29863939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European surveillance activities EARSS and ESAC in the context of ABS International.
    Metz-Gercek S; Mittermayer H
    Wien Klin Wochenschr; 2008; 120(9-10):264-7. PubMed ID: 18545949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.
    Gyssens IC
    Clin Microbiol Infect; 2008 Oct; 14(10):889-91. PubMed ID: 18828849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.